Plunkett Research Online: HedgePath Pharmaceuticals Inc

HEDGEPATH PHARMACEUTICALS INC (HPPI:PINX) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

HedgePath Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It discovers, develops and commercializes therapeutics for the patients with cancer. The firm's main focus is on the development of therapies for skin, lung and prostate cancers in the United States of America market. Its p.....



HedgePath Pharmaceuticals Inc
Ticker: HPPI
Exchange: PINX
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 813 864-2559
Fax: 813 527-0500
Address: 324 S. Hyde Park Avenue
Suite 350
Tampa, FL 33606 United States

Types Of Business
Industry Ranks

Industry NAICS code:

Pharmaceuticals, Biopharmaceuticals, Generics and Drug Manufacturing
ContactsDescription
James CauseyDirector
Samuel SearsDirector
See More
HedgePath Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It discovers, develops and commercializes therapeutics for the patients with cancer. The firm's main focus is on the development of therapies for skin, lung and prostate cancers in the United States of America market. Its p.....See More See More

Auditor: Cherry Bekaert LLP
Legal Advisor:
$USD, In whole numbers,
except marked * or %
201720162015201420132012
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
NameTitleSalary (US$)Bonus (US$)
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: